AF
KZIA

Allworth Financial’s Kazia Therapeutics KZIA Stock Holding History

Allworth Financial’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8 Hold
1
– – ﹤0.01% 5158
2025
Q4 		$7 Hold
1
– – ﹤0.01% 4971
2025
Q3 		$8 Hold
1
– – ﹤0.01% 4878
2025
Q2 		$7 Buy
+1
New +$5 ﹤0.01% 4561
2025
Q1 		– Sell
-2
Closed -$12 – 4039
2024
Q4 		$11 Hold
2
– – ﹤0.01% 3909
2024
Q3 		$38 Hold
2
– – ﹤0.01% 3698
2024
Q2 		$46 Hold
2
– – ﹤0.01% 3628
2024
Q1 		$27 Hold
2
– – ﹤0.01% 3551
2023
Q4 		$39 Hold
2
– – ﹤0.01% 3382
2023
Q3 		$87 Hold
2
– – ﹤0.01% 3352
2023
Q2 		$101 Hold
2
– – ﹤0.01% 3172
2023
Q1 		$90 Buy
+2
New +$96 ﹤0.01% 3104

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Allworth Financial's KZIA Position: Q1 2026 in Review

Allworth Financial held its Kazia Therapeutics (KZIA) position steady in Q1 2026 at 1 share worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #5158.

Allworth Financial first reported a position in KZIA in Q1 2023 and has held it in 12 quarters since. The position peaked at $101 in Q2 2023. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Allworth Financial held 1 share of Kazia Therapeutics worth $8 as of Q1 2026.
  • Allworth Financial left its Kazia Therapeutics share count unchanged in Q1 2026.
  • Kazia Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5158 holding.
  • Allworth Financial first reported a position in Kazia Therapeutics in Q1 2023 and has held it in 12 quarters since.
  • Allworth Financial's Kazia Therapeutics position peaked at $101 in Q2 2023.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.